Avadel Pharmaceuticals (AVDL) Insider Trading & Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AVDL Stock Alerts $17.81 -0.01 (-0.06%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Avadel Pharmaceuticals (NASDAQ:AVDL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$414,400.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.09 M Get AVDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Avadel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVDL Insider Buying and Selling by Quarter Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Avadel Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/16/2024Thomas S MchughCFOBuy2,000$14.50$29,000.00 12/28/2023Mark Anthony MccamishDirectorSell75,000$14.53$1,089,750.00 8/14/2023Thomas S MchughCFOBuy2,000$14.45$28,900.00 8/10/2023Geoffrey Michael GlassDirectorBuy14,000$13.40$187,600.00 8/10/2023Gregory J DivisCEOBuy10,000$13.20$132,000.00 5/9/2023Linda PalczukDirectorBuy2,500$14.76$36,900.00 (Data available from 1/1/2013 forward) AVDL Insider Trading Activity - Frequently Asked Questions Who is on Avadel Pharmaceuticals's Insider Roster? The list of insiders at Avadel Pharmaceuticals includes Eric J Ende, Geoffrey Michael Glass, Gregory J Divis, Linda Palczuk, Mark Anthony Mccamish, and Thomas S Mchugh. Learn more on insiders at AVDL. What percentage of Avadel Pharmaceuticals stock is owned by insiders? 4.00% of Avadel Pharmaceuticals stock is owned by insiders. Learn more on AVDL's insider holdings. Which Avadel Pharmaceuticals insiders have been buying company stock? The following insiders have purchased AVDL shares in the last 24 months: Eric J Ende ($32,400.00), Geoffrey Michael Glass ($187,600.00), Gregory J Divis ($132,000.00), Linda Palczuk ($67,300.00), and Thomas S Mchugh ($203,900.00). How much insider buying is happening at Avadel Pharmaceuticals? Insiders have purchased a total of 112,500 AVDL shares in the last 24 months for a total of $623,200.00 bought. Which Avadel Pharmaceuticals insiders have been selling company stock? The following insider sold AVDL shares in the last 24 months: Mark Anthony Mccamish ($1,089,750.00). How much insider selling is happening at Avadel Pharmaceuticals? Insiders have sold a total of 75,000 Avadel Pharmaceuticals shares in the last 24 months for a total of $1,089,750.00 sold. More Insider Trading Tools from MarketBeat Related Companies: AGIO Insider Buying SUPN Insider Buying AMRX Insider Buying HRMY Insider Buying ARDX Insider Buying EWTX Insider Buying NAMS Insider Buying PTGX Insider Buying GPCR Insider Buying DVAX Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:AVDL) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.